Indium In-111 altumomab pentetate

DB17334ExperimentalProtein Based Therapies

Indium In-111 altumomab pentetate: Overview.

Resolves to

Compound
UNIIAT2NU9VQ6MCAS156586-92-4

Which companies are running trials of Indium In-111 altumomab pentetate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In